Chiropractors in Peyton, CO Accepting Medicare

3 Chiropractors found. Showing 1 - 3

Good Life Chiropractic Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 7495 Mclaughlin Rd, Suite 103, Peyton, CO 80831 Phone: 719-469-2657

Palmer Chiropractic, Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 7671 Mclaughlin Rd, Peyton, CO 80831 Phone: 719-494-1395

Chiropractic Lifestyles, Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 11605 Meridian Market Vw, Suite # 142, Peyton, CO 80831 Phone: 719-475-2455    Fax: 719-475-2254

News Archive

Advancing nanoparticle-based imaging and therapy of brain cancer

Brain cancer is one of the most difficult malignancies to detect and treat, in large part because of the difficulty in getting imaging and therapeutic agents past the so-called blood-brain barrier and into the brain.

Danish-American researchers find new way to treat chronic inflammation

Researchers from Aarhus University Hospital and Aarhus University in Denmark in collaboration with researchers from Colorado in the United States have found a new way to treat the inflammation involved in chronic diseases such as psoriasis, asthma and HIV.

DSM Pharmaceutical Products announces manufacturing alliance with Galenix

DSM Pharmaceutical Products today announced that it has made a manufacturing alliance with Galenix, Saint Jean D'Illac, France, where DSM will be the preferred commercial scale manufacturing partner for Galenix commercial products on a global basis.

Oncolytics' REOLYSIN granted EMA Orphan Drug Designation for pancreatic cancer treatment

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of pancreatic cancer.

Bern researchers develop active substance for treating Duchenne muscular dystrophy

Duchenne muscular dystrophy is a congenital disease which causes muscle degeneration and eventual death in teenagers. Recently, researchers from Bern developed an active substance, which they together with an international team tested successfully.

Read more Medical News

› Verified 5 days ago